Institutional investors hold a majority ownership of MRK through the 75.78% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
USS INVESTMENT MANAGEMENT LTD. Bought 285.3 Thousand shares of Merck
BMO ASSET MANAGEMENT, INC. Bought 105.0 Thousand shares of Merck
ALLIANZ GLOBAL INVESTORS EUROPE ... Bought 103.1 Thousand shares of Merck